Home2196 • HKG
Follow
Shanghai Fosun Pharmaceutical (Group) Ord Shs H
Previous close
$12.72
Day range
$12.58 - $13.02
Year range
$12.40 - $24.15
Market cap
59.80B HKD
Avg Volume
2.78M
P/E ratio
7.90
Dividend yield
3.59%
Market news
.INX
0.23%
Financials
Income Statement
Revenue
Net income
(CNY) | Sep 2023info | Y/Y change |
---|---|---|
Revenue | 9.30B | -9.44% |
Operating expense | 4.24B | 0.19% |
Net income | 505.59M | -43.85% |
Net profit margin | 5.43 | -38.01% |
Earnings per share | — | — |
EBITDA | 536.59M | -53.37% |
Effective tax rate | 4.46% | — |
Balance Sheet
Total assets
Total liabilities
(CNY) | Sep 2023info | Y/Y change |
---|---|---|
Cash and short-term investments | 15.81B | -5.04% |
Total assets | 110.77B | 6.17% |
Total liabilities | 54.78B | 7.21% |
Total equity | 55.98B | — |
Shares outstanding | 2.67B | — |
Price to book | 0.74 | — |
Return on assets | 0.01% | — |
Return on capital | 0.02% | — |
Cash Flow
Net change in cash
(CNY) | Sep 2023info | Y/Y change |
---|---|---|
Net income | 505.59M | -43.85% |
Cash from operations | 651.63M | -51.55% |
Cash from investing | -922.27M | 46.30% |
Cash from financing | -1.80B | -170.95% |
Net change in cash | -1.98B | -182.01% |
Free cash flow | -4.04B | -27.22% |
About
Shanghai Fosun Pharmaceutical Co., Ltd. is a Chinese pharmaceutical company. It is mostly owned by Fosun International.
As of 2018, the A shares of the company is a constituent of SSE 180 Index as well as its sub-index SSE MidCap Index. The company was ranked 1,840th in 2020 edition of the Forbes Global 2000, a list of top listed companies of the world. Wikipedia
CEO
Founded
1994
Website
Employees
40,370